Allogeneic haematopoietic stem cell transplantation is a curative therapy for blood cancers; but results in the development of graft-versus-host disease (GVHD) in up to 70% of recipients. During GVHD, tissue damage results in ATP release into the extracellular compartment activating P2X7 on antigen presenting cells, leading to the release of pro-inflammatory cytokines and subsequent activation of donor T cells. Therefore, the aim of this study was to examine murine (m) P2rx7 and human (h) P2RX7 gene expression in GVHD target organs of humanised mice, and further characterise disease impact in these organs. Methods: NOD-scid IL2Rγnull (NSG) mice were injected with human peripheral blood mononuclear cells (hu-PBMC-NSG mice) or PBS (control). Leukocytes were assessed by flow cytometry; gene expression was measured by qPCR, and tissue sections examined by histology. Results: Compared to control mice, hu-PBMC-NSG mice had increased mP2rx7 and mP2rx4 expression in the duodenum, ileum and skin. hP2RX7 was expressed in all tissues examined. hu-PBMC-NSG mice also displayed increased mReg3g expression in the duodenum and ileum, despite limited histological gut GVHD. hu-PBMC-NSG mice showed histological evidence of GVHD in the skin, liver and lung. Compared to control mice, hu- PBMC-NSG mice displayed increased ear swelling. Conclusion: Combined this data reveals that P2rx7 is upregulated in gut and skin GVHD and that P2RX7 is present in target tissues of GVHD, corresponding to human leukocyte infiltration. Data also reveals increased mReg3g expression and ear swelling in hu-PBMC-NSG mice, offering new measurements of early stage gut GVHD and skin GVHD, respectively.

This content is only available as a PDF.
This is an Accepted Manuscript; not the final Version of Record. Archiving permitted only in line with the archiving policy of Portland Press Limited.